Arca
Skip to content
Tools
Tools

GRAIL, Inc.

4 private offerings reported to the SEC on Form D since 2016, $2.2B sold in all. Biotech, California.

  • Form D offerings: 4
  • Reported sold: $2.2B
  • Newest: Nov 7, 2025
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Nov 7, 2025—$325.0M$325.0MGRAIL, Inc.Biotech · CaliforniaNot amended0001699031-25-000183
Dec 12, 2019—$388.4M$425.0MGrail, Inc.Biotech · CaliforniaMay 7, 20200001699031-19-000002
May 25, 2018—$300.0MOpen-endedGrail, Inc.Biotech · CaliforniaNot amended0000950103-18-006536
Mar 14, 2017—$1.2BOpen-endedGrail, Inc.Biotech · CaliforniaJan 11, 20180001699031-17-000001

SEC Profile

From the company's EDGAR record
Ticker
GRAL
Business address
Sunnyvale, Ca
Incorporated in
Delaware
SEC industry
Services-Medical Laboratories
Former names
Grail, LLC
All SEC filings
CIK 1699031 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.